Developer docs
API playgroundTry for free, no card

Search company profiles

Prism TPO

Full company profile

uuid00557hs

Namestring
Prism TPO
Legal namestring
Prism Transparent Purchasing Organization
Websiteurl
prismtpo.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Prism TPO (legal name: Prism Transparent Purchasing Organization) is a venture-backed Group Purchasing Organization built specifically for independent oncology practices in the United States. Headquartered in Nashville, TN, the company operates a transparent purchasing model that it claims cuts over 80% of traditional drug pricing components (such as retrospective distribution rebates) in favor of upfront, predictable pricing. As of 2024, the Prism network represents over $1.2 billion in annual oncology drug spend across 16 leading independent community oncology practices, and has been recognized by 17 pharmaceutical manufacturers as an official aggregator spanning 36 oncology drug contracts.

The company's core product is the Drug Pricing Transparency Platform, launched in 2025, which integrates live distributor pricing, GPO contract economics, and reimbursement data into a unified view of drug costs. The platform enables practices to assess drug profitability, compare therapeutic alternatives, and make purchasing decisions without relying on siloed spreadsheets. The platform is built on a cloud-native stack using GitHub Codespaces, AWS CDK, and AI-native developer tooling (Cursor IDE). Planned roadmap enhancements include predictive modeling for purchase forecasting and anomaly detection/scenario planning. Prism TPO is a partner of ONCare Alliance, is backed by Obvious Ventures, and is led by Founder & CEO Tesh Khullar alongside a four-person executive team.

The business model is a GPO membership/purchasing fee structure generating recurring revenue through transparent, quote-based pricing with monthly billing. The go-to-market is sales-led, with direct field engagement targeting practice CEOs and Directors of Pharmacy across mid-to-large independent oncology practices. The company emphasizes transparency, alignment with member practices, and direct pharmaceutical manufacturer partnerships as its core value proposition, with reported claims that 95% of switching practices see measurable savings.

Short descriptiontext

Prism TPO is a transparent Group Purchasing Organization serving independent oncology practices in the U.S., aggregating $1.2B in annual drug spend across 16 practices through a Drug Pricing Transparency Platform and direct pharmaceutical manufacturer partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNashville, United States
HQ citystring
Nashville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
group purchasing organization, drug pricing transparency, oncology GPO services, pharmaceutical purchasing network, healthcare procurement
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Oncology Drug Procurement
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1GPO Membership/Purchasing Fees
TypeSubscription Recurring
Description

Prism TPO operates as a transparent purchasing organization, generating revenue through membership fees and/or transaction-based purchasing fees from independent oncology practices. Practices pay to access the network's collective purchasing power and transparent pricing model.

prismtpo.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details1 tier
1Transparent upfront pricing model
ModelOtherBilling cadenceMonthly
Notes

Pricing components reduced by over 80% compared to traditional GPO/distributor models. No retrospective distribution rebates - only upfront, predictable pricing. Quote-based pricing tailored to practice size.

prismtpo.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Prism TPO operates a transparent purchasing organization (GPO) purpose-built for independent oncology practices. Its core offering is the Drug Pricing Transparency Platform, which integrates live distributor pricing, GPO contract economics, and reimbursement data into a unified view, enabling practices to assess drug profitability, compare therapeutic alternatives, and make informed purchasing decisions. The platform is supported by 36 oncology drug contracts across 17 pharmaceutical manufacturers and cuts over 80% of traditional pricing components such as retrospective distribution rebates.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Prism TPO operates as the first and only transparent purchasing organization (GPO) built exclusively for independent oncology practices. The core offering is the Drug Pricing Transparency Platform, which integrates live distributor pricing, GPO contract economics, and reimbursement data into a unified dashboard. The platform cuts over 80% of traditional pricing components (such as retrospective distribution rebates), leaving only upfront and predictable pricing. Prism TPO's model is augmented by its network of 18 pharmaceutical partnerships recognized across 36 oncology drug contracts, which provide member practices with clearly defined savings opportunities. The company represents over $1.2 billion in annual oncology drug spend across 16 independent community oncology practices. As a partner of ONCare Alliance, Prism TPO also participates in collaborative industry initiatives.

Product and service2 records
1Drug Pricing Transparency Platform
CategoryDrug pricing transparency software
Description

A software platform that integrates live distributor pricing, GPO contract economics, and reimbursement data into a unified view of drug costs. It enables independent oncology practices to assess drug profitability, compare therapeutic alternatives, and make informed purchasing decisions without relying on siloed spreadsheets and manual reporting.

2Transparent GPO Membership & Purchasing Network
CategoryHealthcare group purchasing organization services
Description

A purchasing organization membership service that gives independent oncology practices access to collective purchasing power, transparent upfront pricing, and direct pharmaceutical manufacturer partnerships across 36 oncology drug contracts. Members pay recurring purchasing and/or membership fees to join the network.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Prism TPO is a partner of ONCare Alliance, a network of independent oncology practices. Prism participates in ONCare National Leadership Summit and collaborates on advancing the interests of community oncology providers. Strategic alliance positioning Prism within the independent oncology ecosystem.

217 Pharmaceutical Manufacturers
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Prism TPO has been recognized by 17 leading pharmaceutical manufacturers as an official aggregator spanning 36 oncology drug contracts. Manufacturers partner with Prism to gain direct pathway to community-based oncology providers through streamlined contracting and rebate management. Enables practices to access competitive, sustainable drug pricing and additional savings opportunities.

prismtpo.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Major pharmaceutical distributor with specialty oncology distribution capabilities (including through US Oncology Network). Competes with Prism on the same drug-purchasing economics for community oncology, but with far broader scale and manufacturer relationships.

TypeEmerging player
Description

A specialty pharmacy focused on oncology and rare-disease therapies that negotiates directly with manufacturers on behalf of patients and providers. Overlaps with Prism in serving oncology drug economics and manufacturer relationships, though delivered through pharmacy fulfillment rather than a GPO model.

TypeEmerging player
Description

Specialty pharmacy integrator focused on embedding specialty pharmacy capabilities into health systems and provider practices. Comparable to Prism at the intersection of specialty drug economics and provider enablement, though anchored in health-system partnerships rather than independent practices.

TypeBroad incumbent
Description

Top-three U.S. pharmaceutical distributor with specialty drug and oncology distribution capabilities. Comparable to Prism in serving oncology drug purchasing, though as part of a much broader healthcare distribution portfolio rather than a transparent-oncology focus.

TypeEmerging player
Description

Specialty pharmacy services company that provides contracting, distribution, and patient access services across specialty therapies including oncology. Comparable to Prism in aggregating manufacturer contracts and serving independent specialty providers, but with a broader specialty-pharmacy lens.

6ION Solutions
TypeDirect peer
Description

An oncology-focused GPO and practice services organization (now part of McKesson) that aggregates drug purchasing and provides practice management services for community oncology providers — directly comparable to Prism TPO's target customer, business model, and product category.

TypeDirect peer
Description

A network of independent community oncology practices affiliated with McKesson. Directly serves the same customer base as Prism TPO and offers competing practice support, drug-purchasing, and GPO economics to independent community oncologists.

8McKesson
TypeBroad incumbent
Description

Largest U.S. pharmaceutical distributor with extensive specialty/oncology distribution and an embedded oncology GPO (ION Solutions). Overlaps with Prism in oncology drug purchasing and contract aggregation, but operates at vastly greater scale and as part of a diversified portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Prism TPO

Oncology Drug Procurementprismtpo.com

Prism TPO is a transparent Group Purchasing Organization serving independent oncology practices in the U.S., aggregating $1.2B in annual drug spend across 16 practices through a Drug Pricing Transparency Platform and direct pharmaceutical manufacturer partnerships.

What Prism TPO does

Prism TPO (legal name: Prism Transparent Purchasing Organization) is a venture-backed Group Purchasing Organization built specifically for independent oncology practices in the United States. Headquartered in Nashville, TN, the company operates a transparent purchasing model that it claims cuts over 80% of traditional drug pricing components (such as retrospective distribution rebates) in favor of upfront, predictable pricing. As of 2024, the Prism network represents over $1.2 billion in annual oncology drug spend across 16 leading independent community oncology practices, and has been recognized by 17 pharmaceutical manufacturers as an official aggregator spanning 36 oncology drug contracts.

The company's core product is the Drug Pricing Transparency Platform, launched in 2025, which integrates live distributor pricing, GPO contract economics, and reimbursement data into a unified view of drug costs. The platform enables practices to assess drug profitability, compare therapeutic alternatives, and make purchasing decisions without relying on siloed spreadsheets. The platform is built on a cloud-native stack using GitHub Codespaces, AWS CDK, and AI-native developer tooling (Cursor IDE). Planned roadmap enhancements include predictive modeling for purchase forecasting and anomaly detection/scenario planning. Prism TPO is a partner of ONCare Alliance, is backed by Obvious Ventures, and is led by Founder & CEO Tesh Khullar alongside a four-person executive team.

The business model is a GPO membership/purchasing fee structure generating recurring revenue through transparent, quote-based pricing with monthly billing. The go-to-market is sales-led, with direct field engagement targeting practice CEOs and Directors of Pharmacy across mid-to-large independent oncology practices. The company emphasizes transparency, alignment with member practices, and direct pharmaceutical manufacturer partnerships as its core value proposition, with reported claims that 95% of switching practices see measurable savings.

Prism TPO firmographics

Firmographics
Name
Prism TPO
Legal name
Prism Transparent Purchasing Organization
Website
https://prismtpo.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
Prism TPO is a transparent Group Purchasing Organization serving independent oncology practices in the U.S., aggregating $1.2B in annual drug spend across 16 practices through a Drug Pricing Transparency Platform and direct pharmaceutical manufacturer partnerships.
Ownership category
akta.pro rank

Where Prism TPO is headquartered

Location

Headquarters

HQ city
Nashville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Prism TPO business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. GPO Membership/Purchasing Fees: Prism TPO operates as a transparent purchasing organization, generating revenue through membership fees and/or transaction-based purchasing fees from independent oncology practices. Practices pay to access the network's collective purchasing power and transparent pricing model.

Pricing tiers

ModelBillingPrice
OtherMonthlyTransparent upfront pricing model

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Prism TPO product offering

Product offering

Core offering

Prism TPO operates a transparent purchasing organization (GPO) purpose-built for independent oncology practices. Its core offering is the Drug Pricing Transparency Platform, which integrates live distributor pricing, GPO contract economics, and reimbursement data into a unified view, enabling practices to assess drug profitability, compare therapeutic alternatives, and make informed purchasing decisions. The platform is supported by 36 oncology drug contracts across 17 pharmaceutical manufacturers and cuts over 80% of traditional pricing components such as retrospective distribution rebates.

Product overview

Prism TPO operates as the first and only transparent purchasing organization (GPO) built exclusively for independent oncology practices. The core offering is the Drug Pricing Transparency Platform, which integrates live distributor pricing, GPO contract economics, and reimbursement data into a unified dashboard. The platform cuts over 80% of traditional pricing components (such as retrospective distribution rebates), leaving only upfront and predictable pricing. Prism TPO's model is augmented by its network of 18 pharmaceutical partnerships recognized across 36 oncology drug contracts, which provide member practices with clearly defined savings opportunities. The company represents over $1.2 billion in annual oncology drug spend across 16 independent community oncology practices. As a partner of ONCare Alliance, Prism TPO also participates in collaborative industry initiatives.

Differentiator

Problem solved

Functional benefit

Products and services

  • Drug Pricing Transparency Platform A software platform that integrates live distributor pricing, GPO contract economics, and reimbursement data into a unified view of drug costs. It enables independent oncology practices to assess drug profitability, compare therapeutic alternatives, and make informed purchasing decisions without relying on siloed spreadsheets and manual reporting.
  • Transparent GPO Membership & Purchasing Network A purchasing organization membership service that gives independent oncology practices access to collective purchasing power, transparent upfront pricing, and direct pharmaceutical manufacturer partnerships across 36 oncology drug contracts. Members pay recurring purchasing and/or membership fees to join the network.

Companies that use Prism TPO

Customer profile

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Prism TPO technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Prism TPO partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • ONCare AlliancecoreStrategic or Co-development PartnerPrism TPO is a partner of ONCare Alliance, a network of independent oncology practices. Prism participates in ONCare National Leadership Summit and collaborates on advancing the interests of community oncology providers. Strategic alliance positioning Prism within the independent oncology ecosystem.
  • 17 Pharmaceutical ManufacturerscoreStrategic or Co-development PartnerPrism TPO has been recognized by 17 leading pharmaceutical manufacturers as an official aggregator spanning 36 oncology drug contracts. Manufacturers partner with Prism to gain direct pathway to community-based oncology providers through streamlined contracting and rebate management. Enables practices to access competitive, sustainable drug pricing and additional savings opportunities.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Prism TPO competitors and assessment

Company assessment

Broad incumbents

  • Cencora (formerly AmerisourceBergen): Major pharmaceutical distributor with specialty oncology distribution capabilities (including through US Oncology Network). Competes with Prism on the same drug-purchasing economics for community oncology, but with far broader scale and manufacturer relationships.
  • Cardinal Health: Top-three U.S. pharmaceutical distributor with specialty drug and oncology distribution capabilities. Comparable to Prism in serving oncology drug purchasing, though as part of a much broader healthcare distribution portfolio rather than a transparent-oncology focus.
  • McKesson: Largest U.S. pharmaceutical distributor with extensive specialty/oncology distribution and an embedded oncology GPO (ION Solutions). Overlaps with Prism in oncology drug purchasing and contract aggregation, but operates at vastly greater scale and as part of a diversified portfolio.

Emerging players

  • Onco360: A specialty pharmacy focused on oncology and rare-disease therapies that negotiates directly with manufacturers on behalf of patients and providers. Overlaps with Prism in serving oncology drug economics and manufacturer relationships, though delivered through pharmacy fulfillment rather than a GPO model.
  • Shields Health Solutions: Specialty pharmacy integrator focused on embedding specialty pharmacy capabilities into health systems and provider practices. Comparable to Prism at the intersection of specialty drug economics and provider enablement, though anchored in health-system partnerships rather than independent practices.
  • Asembia: Specialty pharmacy services company that provides contracting, distribution, and patient access services across specialty therapies including oncology. Comparable to Prism in aggregating manufacturer contracts and serving independent specialty providers, but with a broader specialty-pharmacy lens.

Direct peers

  • ION Solutions: An oncology-focused GPO and practice services organization (now part of McKesson) that aggregates drug purchasing and provides practice management services for community oncology providers — directly comparable to Prism TPO's target customer, business model, and product category.
  • US Oncology Network (McKesson): A network of independent community oncology practices affiliated with McKesson. Directly serves the same customer base as Prism TPO and offers competing practice support, drug-purchasing, and GPO economics to independent community oncologists.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Prism TPO social profiles

Digital presence

Prism TPO financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Prism TPO leadership team

Management profile

Number of profiles

Profiles4 records

Prism TPO funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Prism TPO M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Prism TPO

What does Prism TPO do?

Prism TPO operates a transparent purchasing organization (GPO) purpose-built for independent oncology practices. Its core offering is the Drug Pricing Transparency Platform, which integrates live distributor pricing, GPO contract economics, and reimbursement data into a unified view, enabling practices to assess drug profitability, compare therapeutic alternatives, and make informed purchasing decisions. The platform is supported by 36 oncology drug contracts across 17 pharmaceutical manufacturers and cuts over 80% of traditional pricing components such as retrospective distribution rebates.

Is Prism TPO a public or private company?

Prism TPO is a private company. It is classified as venture growth investor backed and is currently operating.

When was Prism TPO founded?

Prism TPO was founded in -1. It employs 11 to 50 people.

Where is Prism TPO based?

Prism TPO is headquartered in Nashville, United States, in the North America region.

How does Prism TPO make money?

One revenue line is on record: GPO Membership/Purchasing Fees.

Who are Prism TPO's main competitors?

Broad incumbents on record are Cencora (formerly AmerisourceBergen), Cardinal Health and McKesson. Emerging players are Onco360, Shields Health Solutions and Asembia. Direct peers are ION Solutions and US Oncology Network (McKesson).

Does Prism TPO have an API?

No public API is recorded for Prism TPO.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales